{"Bitopic": ["bisteric", "dualsteric", "bivalent", "bitopic", "dualsterism", "bisterism", "bitopism", "ago-allosteric", "ago-allosterism", "ago-alosterism", "ago-alosteric", "ago allosteric", "ago allosterism", "ago alosteric", "ago allosterism"], 
 "Covalent": ["covalent inhibitor", "covalent inhibition", "covalent activator", "covalent activation", "covalent inactivator", "covalent inactivator", "covalent inactivation", "covalent binder", "covalent binding", "covalent probe", "covalent ligand", "covalent target", "covalent effect", "covalently", "irreversible inhibitor", "irreversible inhibition", "irreversible activator", "irreversible activation", "irreversible inactivator", "irreversible inactivation", "irreversible binder", "irreversible binding", "irreversible probe", "irreversible ligand", "irreversible target", "irreversible effect", "irreversibly", "warhead", "Neratinib", "Afatinib", "BIBW-2992", "PF-00299804", "Carfilzomib", "Abiraterone", "Iniparib", "BSI201", "PCI-32765", "Telaprevir", "Boceprevir", "Zomepirac", "Daunomycin", "Adriamycin", "Esomeprazole", "Clopidogrel", "Lansoprazole"],
 "Allo1": ["regulatory site", "secondary binding site", "secondary pocket", "nonsubstrate", "non-substrate", "uncompetitive", "un-comptetitive", "noncompetitive", "non-competitive", "indirectly inhibit", "indirectly activate", "indirect activation", "indirect inhibition", "modulatory actions", "positive modulator", "negative modulator", "receptor modulator", "allosteric modulator", "allosteric", "allosterism", "alosteric", "alosterism", "allostery", "alostery"], 
 "Ortho1": ["BTZ", "benzothiazepine", "DPP", "diphenylmethylpiperazine", "PAA", "phenylalkylamine","competitive inhibitor", "competitive activator", "competitive inhibition", "competitive activation", "competitive-inhibition", "competitive interaction", "competitive receptor binding", "competitive binding", "competitive assay", "competitive agonist", "competitive antagonist", "primary binding site", "primary binding-site", "primary bindingsite", "primary pocket", "primary-pocket", "substrate-competitive", "substrate competitive", "directly inhibit", "directly activate"], 
 "Allo2": ["Bay K 8644", "BayK8644", "BAYK8644", "DHP", "dihydropyridine", "PYT", "pyrimidine-2,4,6-trione", "intracellular domain", "intracellular binding", "intracellular ligand", "intracellular site", "non-nucleoside analog", "nonnucleoside analog", "NNRTI", "non-nucleoside analog", "nonnucleoside analog", "LUF5484", "PD81723", "Benzodiazepines", "Amiliorides", "Reparixin", "Agmatine", "PSNCBAM-1", "I-TAC", "Prichosanthin", "Plerixaflor", "Trichosanthin", "Ancriviroc", "Vicriviroc", "Aplaviroc", "Maraviroc", "Furan-1", "Brucine", "BQCA", "Tacrine", "Stautosporine", "Gallamine", "Alcuronium", "Heparin", "Cannabidiol", "Loeamide", "Antalarmin", "L-168049", "Fendeline", "Cinacalcet", "JNJ16259685"], 
 "Ortho2": ["natural ligand", "primary ligand", "endogenous ligand", "endogenous agonist", "endogenous antagonist", "endogenous blocker", "endogenous activation", "endogenous inhibition", "endogenous binding", "agonist activity", "antagonist activity", "fly trap", "flytrap", "fly-trap", "NRTI"],
 "Ortho3": ["orthostery", "orthosterism", "orthosteric", "orthosterically"]
}